指南与共识创伤与烧伤消化、代谢与肾脏急症

国际多学科同行共识:止血粉在外科实践中的最佳使用

An international multidisciplinary peer-driven consensus on the optimal use of hemostatic powders in surgical practice.
指南 / 共识 · Updates Surg · 2021-07-28
一句话结论欧洲多学科专家组基于79名高手术量外科医生的调查共识,提出16条关于止血粉在外科中最佳使用的关键推荐。

该共识由欧洲多学科止血专家指导组制定,围绕止血粉何时使用、使用证据、获益、安全注意事项及不同外科专科的考虑五个关键主题,形成37条陈述。调查发送给欧洲128名高手术量外科医生(乳腺外科、妇科及产科、普通与急诊外科、胸外科、泌尿外科),收到79份回复。共识达成情况:27条(73%)为非常高度共识(≥90%同意),8条(22%)为高度共识(≥75%同意),2条(5%)未达成共识。指导组基于共识评分产生16条关键推荐,认为可通过使用止血粉减少术后出血及相关并发症来改善患者结局。

要点

  • 共识定义:≥75%受访者同意为高度共识,≥90%为非常高度共识;37条陈述中27条(73%)达非常高度共识,8条(22%)达高度共识,2条(5%)未达成共识。
  • 调查对象为欧洲128名高手术量外科医生,覆盖乳腺外科、妇科及产科、普通与急诊外科、胸外科和泌尿外科,共收到79份回复。
  • 指导组从文献和个人经验中确定五个关键主题:何时使用止血粉、使用证据、获益、安全注意事项以及不同外科专科的考虑。
  • 基于共识评分,指导组产生16条关键推荐,认为使用止血粉可减少术后出血及其相关并发症,从而改善患者结局。
  • 原文指出目前尚无关于止血粉在外科中最佳使用的具体指南或推荐,止血粉是局部止血剂的一个亚组,可作为辅助手段处理多种情况下的棘手出血。

适用人群与场景

  • 欧洲高手术量外科医生,涉及乳腺外科、妇科及产科、普通与急诊外科、胸外科和泌尿外科。

诊断标准与关键阈值

  • 共识达成标准:≥75%受访者同意为高度共识,≥90%为非常高度共识。

研究设计与关键结果

  • 共识制定方法:欧洲多学科指导组从文献和个人经验确定五个关键主题,形成37条陈述,对128名欧洲高手术量外科医生进行在线调查,收到79份回复。
  • 共识达成情况:27条(73%)陈述为非常高度共识(≥90%同意),8条(22%)为高度共识(≥75%同意),2条(5%)未达成共识。
  • 基于共识评分,指导组产生16条关键推荐,认为可改善患者结局。

证据类型、等级与局限

  • 证据类型:国际多学科同行驱动共识(指南/共识)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出具体临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Bleeding is a consequence of insufficient hemostasis and excessive bleeding at a surgical site is associated with an increased risk of post-operative infection, transfusion and re-operation, in addition to increased hospital length of stay and costs. Surgeons employ a range of methods to achieve hemostasis, including topical hemostatic agents of differing composition and properties. Hemostatic powders are a sub-group of topical hemostats, which can be used in helping as adjuncts to manage troublesome bleeding in a variety of situations. As this technology is relatively new and potentially not well known by the broad surgical community, no specific guidelines or recommendations for the optimal use of hemostatic powders in surgery currently exist. A steering group throughout Europe of multidisciplinary surgeons, expert in hemostasis and hemostatics, identified from literature and from personal experience, five key topics. When to use hemostatic powder, the evidence for use, benefits of use, safety remarks and considerations in various surgical specialties. Thirty-seven statements were subsequently drawn from these five key topics. An online survey was sent to 128 high-volume surgeons working in breast surgery, gynaecological and obstetric surgery, general and emergency surgery, thoracic surgery and urological surgery in Europe to assess agreement (consensus) with these statements. Consensus was defined as high if ≥ 75% and very high if ≥ 90% of respondents agreed with a statement. A total of 79 responses were received and consensus among the surgical experts was very high in 27 (73%) statements, high in 8 (22%) statements and was not achieved in 2 (5%) statements. Based on the consensus scores, the steering group produced 16 key recommendations which they considered could improve patient outcomes by reducing post-operative bleeding and its associated complications using hemostatic powder.

来源:Updates Surg,查看原文。版权归原作者所有。

参考来源

  1. Eden C, Buonomo OC, Busch J, et al. An international multidisciplinary peer-driven consensus on the optimal use of hemostatic powders in surgical practice. Updates Surg. 2021. PMID: 34322783. doi:10.1007/s13304-021-01136-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。